Registering for more than one person? A TMA login is required for each person you register. Need help? Contact the TMA Knowledge Center at (800) 880-7955.
You must select a location to proceed.
Yes
No
There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
Adding Registration, Please wait...
You must be logged in to perform this action.
Log in
Cancel
Amphetamines, the Next Epidemic: What History Has Not Taught Us
Recorded Live at TexMed 2022 Annual Meeting
Credit(s):
0.75 AMA PRA Category 1 Credits™ (Enduring)
0.75 ETHICS
0.75 DEA SUD
Amphetamines are riding the wave of the opiate epidemic and creating new challenges for physicians. This session will outline the history of previous stimulant epidemics and how pharmaceutical companies today are using the opioid playbook to boost sales of attention-deficit/hyperactivity disorder (ADHD) treatments. It also will examine the neurochemical basis of addiction and how stimulants create unique addiction sequelae.
Best Bits
Opiates then and now
How the same tactics are being uses again in marketing stimulants
Evolution and ADHD in a tech society
The link between ADHD and psychosis
What is a provider to do?
Learning Objectives
Upon completion of this activity, participants will be able to:
Examine the history of stimulant use disorder and opiate use disorder;
Identify trends and similarities in these epidemics and their iatrogenic components; and
Compare prescribing trends with ADHD treatment standards.
Competencies
This program addresses the following desirable physician attributes: medical knowledge, provide patient center care, interpersonal and communication skills, and professionalism
Recorded: April 30, 2022
Released: June 20, 2022 Expires: June 20, 2025
Return Policy No refunds or exchanges will be processed for this program.
0.75 AMA PRA Category 1 Credits™ (Enduring) The Texas Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Texas Medical Association designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
On select courses, the Texas Medical Association requires physician to complete 70-percent of the test questions correctly to receive credit for this course.
0.75 ETHICS This course has been designated for 0.75 credit(s) of education in medical ethics and/or professional responsibility.
0.75 DEA SUD The Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders. This program is eligible to count towards the training requirement. Participation in this program in no way implies the participant has fully met the federally and state-mandated training requirements. Participants are solely responsible for ensuring any mandated training requirements are completed.
Customers Who Bought This Item Also Bought
(PDF) Sticky Wellness Trends: Cannabidiol and Hemp
(On Demand Webinar) Multimodal Opioid-Sparing Strategies for Acute Pain Management
(On Demand Webinar) Addiction in Chronic Pain Patients: How to Know and What to Do
(On Demand Webinar) Red Flag Behaviors in Pain Management
(On Demand Webinar) Buprenorphine for Pain and Opioid Use Disorders
(On Demand Webinar) Interpretation of Urine Drug Tests in Pain Management
(On Demand Webinar) Screening, Brief Intervention, and Referral to Treatment of Substance Use Disorders (SBIRT)
(CME to Go/Podcast) Opioid Stewardship
(On Demand Webinar) Healthy Conversations: Engaging with Your Patient about Substance Use Disorders
(On Demand Webinar) Shades of Grey
(On Demand Webinar) Management of Chronic Pain Patients with Substance Use Disorders
Adding Registration, Please wait...
